Special Warning : אזהרת שימוש

4.4 Special warnings and precautions for use
Gastrointestinal disorders
Potassium chloride, alone or in combination with other medications may induce ulceration in the gastrointestinal tract, in particular the lower oesophagus and small bowel. This possibility is increased in patients with local, functional or mechanical disorders of the gastrointestinal tract, with cardiovascular disease, or in those on prolonged therapy or receiving anticholinergics. Symptoms or signs suggesting ulceration or obstruction of the tract should be regarded as reasons to discontinue medication immediately (See also section 4.8 Undesirable effects).
Patients with ostomies may have altered intestinal transit times and are better treated with other forms of potassium salts.
Hyperkalaemia
Potassium salts should only be administered with extreme caution to patients with renal dysfunction, hepatic disease (because of the risk of hyperkalaemia), history of or existent peptic ulceration. Monitoring of serum potassium and other electrolytes is particularly necessary in patients with diseases of the heart and kidneys.
Slow K should be used with caution in patients receiving any drug known to have a potential for hyperkalaemia, such as ACE inhibitors, angiotenin –II-receptor antagonists, NSAIDs (e.g. indomethacin), beta-blockers, heparin, digoxin and ciclosporin (see also section 4.5 Interaction with other medicinal products and other forms of interaction).
Treatment Monitoring
Periodic serum potassium determinations are recommended during long term supplementation, especially in clinical conditions which carry a risk of hyperkalaemia (e.g. impaired renal function or heart disease) (see also section 4.5 Interaction with other medicinal products and other forms of interaction).
Other
In some patients, diuretic induced magnesium deficiency will prevent restoration of intracellular deficits of potassium so that hypomagnesaemia should be corrected at the same time as hypokalaemia.
Slow-K contains sucrose (=saccharose). Patients with rare hereditary disorders like fructose-intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not use this medicine


SLO API JUN16 CL V3                                REF Ireland_PI_effective_Feb-2016 

Effects on Driving

4.7 Effects on ability to drive and use machines
None known to date.